Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNC | P24863 | 3/20 | 0.34 |
| ▸ | CDK8 | P49336 | 3/20 | 0.34 |
| ▸ | HASPIN | Q8TF76 | 3/20 | 0.34 |
| ▸ | CDK19 | Q9BWU1 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7288548 | 0.91 | CCNC (0.38) | CCNCCDK8HASPINCDK19 | |
| SCHEMBL7292067 | 0.87 | CCNC (0.31) | CCNCCDK8HASPINCDK19 | |
| SCHEMBL7314077 | 0.86 | FGFR1 (0.32) | CCNCCDK8HASPINCDK19 | |
| SCHEMBL7292758 | 0.85 | CCNC (0.36) | CCNCCDK8HASPINCDK19 | |
| SCHEMBL7290956 | 0.84 | CYP1A2 (0.37) | CCNCCDK8HASPINCDK19 | |
| SCHEMBL7296855 | 0.83 | SMN1; SMN2 (0.34) | CCNCCDK8HASPINCDK19 | |
| SCHEMBL7292380 | 0.83 | CCNC (0.32) | CCNCCDK8HASPINCDK19 | |
| SCHEMBL7299515 | 0.82 | KDM4E (0.33) | — | |
| SCHEMBL7294108 | 0.82 | CA12 (0.40) | CCNCCDK8HASPINCDK19 | |
| SCHEMBL7299541 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0308792-B1 | AZACHROMANE DERIVATIVES | MERCK PATENT GmbH (DE) | 1993-07-28 | — | — | EP | disclosed |
| US-4931454-A | Azachroman derivatives with effects on the cardiovascular system | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1990-06-05 | — | — | US | disclosed |
| EP-0308792-A2 | Azachromane derivatives | MERCK PATENT GmbH (DE) | 1989-03-29 | — | — | EP | disclosed |